Wafaa I. El‐Eraky
- Organic Chemistry top 5%
- Molecular Biology
- Complementary and alternative medicine top 5%
- Pharmacology
- Oncology
- Co-authors
- Dalia O. SalehH. H. FahmySally A. El AwdanAdel S. GirgisSalwa M. NofalAhmed M. Al‐AbdHanaa FaragAyman Salama
- Topics
- Synthesis and biological activity (11 papers)Synthesis and Reactions of Organic Compounds (6 papers)Synthesis and Characterization of Heterocyclic Compounds (5 papers)
- Partner nations
- EgyptSaudi ArabiaUnited States
In The Last Decade
Wafaa I. El‐Eraky
45 papers receiving 838 citations
Peers
Comparison fields: 5 of 101
- Organic Chemistry 373
- Molecular Biology 211
- Complementary and alternative medicine 93
- Pharmacology 88
- Oncology 73
Countries citing papers authored by Wafaa I. El‐Eraky
This map shows the geographic impact of Wafaa I. El‐Eraky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wafaa I. El‐Eraky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wafaa I. El‐Eraky more than expected).
Fields of papers citing papers by Wafaa I. El‐Eraky
This network shows the impact of papers produced by Wafaa I. El‐Eraky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wafaa I. El‐Eraky. The network helps show where Wafaa I. El‐Eraky may publish in the future.
Co-authorship network of co-authors of Wafaa I. El‐Eraky
This figure shows the co-authorship network connecting the top 25 collaborators of Wafaa I. El‐Eraky. A scholar is included among the top collaborators of Wafaa I. El‐Eraky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wafaa I. El‐Eraky. Wafaa I. El‐Eraky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 51 | |
| 3 | ESTROGENS IMPROVE THE CARDIOVASCULAR ALTERATIONS IN FRUCTOSE-INDUCED INSULIN RESISTANT OVARIECTOMIZED RATS | 6 |
| 4 | 14 | |
| 5 | 106 | |
| 6 | 3 | |
| 7 | 10 | |
| 8 | 11 | |
| 9 | Synthesis, Anti-Inflammatory, Analgesic, Molecular Modeling and Admet Studies of Novel Diclofenac Derivatives Containing Leucinyl Moiety | 5 |
| 10 | 26 | |
| 11 | 9 | |
| 12 | 37 | |
| 13 | 37 | |
| 14 | 31 | |
| 15 | 14 | |
| 16 | 42 | |
| 17 | 17 | |
| 18 | Facile synthesis of fused pyrazolo[1,5-a]pyrimidinepyrazolo [1,5-a]triazines and N-sulphonamidopyrazoles as antiinflammatory. | 14 |
| 19 | 26 | |
| 20 | 15 |
About Wafaa I. El‐Eraky
Wafaa I. El‐Eraky is a scholar working on Organic Chemistry, Pharmacology and Biological Psychiatry, having authored 46 papers that have together received 861 indexed citations. Recurring topics across this work include Synthesis and biological activity (11 papers), Synthesis and Reactions of Organic Compounds (6 papers) and Synthesis and Characterization of Heterocyclic Compounds (5 papers). The work is most often cited by research in Toxicology (67 citations), Organic Chemistry (373 citations) and Complementary and alternative medicine (93 citations). Wafaa I. El‐Eraky has collaborated with scholars based in Egypt, Saudi Arabia and United States. Frequent co-authors include Dalia O. Saleh, H. H. Fahmy, Sally A. El Awdan, Adel S. Girgis, Salwa M. Nofal, Ahmed M. Al‐Abd, Hanaa Farag, Ayman Salama, Ragab Said and Tapani Viitala. Their work appears in journals such as PLoS ONE, Molecules and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.